Kringle Pharma (4884) · RiskRestated
Dependence on the Representative Director and Certain Employees
First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Dependence on key executivesA theme 560 companies write about · 560 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2026: 10 of 77 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 560 threads.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「当社では特定人物への依存が強くなり過ぎないよう業務内容を複数で共有するとともに人材の確保及び育成に努めております。」
代表取締役および専門知識を持つ特定従業員への依存リスクと、業務共有・人材確保・育成による対応を再掲している。 - FY2020First statedAnnual report
「Representative Director and President Kiichi Adachi plays an important role in determining management policy, licensing activities and the company’s overall business activities. In addition, because research and development requires specialized knowledge, the company is heavily dependent on certain employees.」
The company discloses its dependence on the representative director responsible for management policy and licensing activities and on employees with specialized knowledge.